Global Market Access Lead (Sr Director)

Kedrion Biopharma, a global leader in plasma-derived therapies, is seeking a dynamic, experienced, and motivated Global Market Access Lead . In this senior role, you will lead the development and execution of U.S.-focused market access strategies, while also shaping and aligning global access approaches that communicate the value of Kedrion’s therapies to payers worldwide. This leader will directly interact and drive engagement with payers, key access providers and government reimbursement agencies as well as other key stakeholders to maximize commercial opportunities and patient access. Your work will ensure that patients gain timely access to our lifesaving and life-improving therapies and products.

The Global Market Access Lead will partner with cross-functional teams—spanning clinical development, medical affairs, regulatory, commercial, and external stakeholders—to secure optimal access and reimbursement outcomes.

What You’ll Do

• Lead Access Strategy: Develop and implement market access strategies with a primary focus on the U.S., while ensuring alignment and scalability across global pipeline and marketed therapies.
• Shape Payer Value Propositions: Create compelling U.S. payer value propositions, define evidence requirements, and ensure integration into global development and launch strategies in collaboration with cross-functional teams.
• Engage Payer Stakeholders: Build and maintain strong relationships with U.S. public and private payers, PBMs, insurers, policy makers, and patient organizations, while also engaging global payers and HTA bodies to champion Kedrion’s therapies and secure favorable coverage, formulary positioning, and reimbursement.
• Support Launch Readiness: Drive U.S. access‑related pre‑launch planning and execution, including payer engagement, pricing support, and value communications, while contributing to Ex‑U.S. launch and geographic expansion strategies.
• Gather and Apply Insights: Synthesize payer and HTA insights into actionable recommendations, identifying risks and opportunities to inform current and future strategies.
• Deliver Strategic Impact: Provide senior leadership with clear perspectives on the U.S. access environment and global market access trends that influence corporate strategy and long‑term growth.
• Inform Clinical Development: Provide strategic access input to clinical programs to ensure evidence generation meets the needs of U.S. / global payers and HTA bodies.
• Advance Evidence Generation: Oversee HEOR and Real‑World Evidence initiatives including cost‑effectiveness analyses, budget impact models, and systematic reviews to support U.S. and global value communication in coordination with global marketing, global medical affairs and other key internal stakeholders.
• Monitor Market Access Trends: Track global market access trends, competitor activities, and healthcare policy changes, with particular attention to U.S. reimbursement and policy dynamics.
• Support HTA Engagement: Lead or support planning and submission activities for EU Joint Clinical Assessment (JCA) and other major HTA processes, ensuring strong alignment with U.S. access strategies and successful execution.
• Collaborate Cross‑Functionally: Partner with regional Market Access, commercial, regulatory, and medical teams to align global strategies with local execution.
• Ensure Scientific Excellence: Drive the generation and publication of high‑quality access‑related data in peer‑reviewed journals and at scientific conferences.
• Build and Lead Teams: Develop and mentor a high‑performing global Market Access function capable of delivering measurable outcomes while operating as a player / coach.

Qualifications

• Bachelor’s degree required; advanced degree (Master’s, PhD, PharmD, MPH, or MBA) strongly preferred.
• At least 10 years of progressive experience in Market Access leadership positions within the biotech/pharma sector, with significant U.S. market access experience, ideally for novel therapies, rare diseases or specialty biologics including plasma derived or infused therapies.
• Deep expertise in U.S. payer systems, reimbursement pathways, and policy environments, with strong working knowledge of global payer systems and HTA processes across major markets (U.S., U.K./EU, and other regions). Proven success in developing payer value propositions, evidence strategies, and access plans leading to positive reimbursement outcomes.
• Experience with HTA submissions (including EU JCA or equivalent) strongly preferred.
• Demonstrated success engaging external stakeholders, including U.S. payers, PBMs, HTA bodies, and health authorities. Experience in rare diseases, hematology, immunology, or neurology preferred.
• Excellent leadership, communication, and cross‑functional collaboration skills.
• Demonstrated ability to think strategically, anticipate payer needs, and innovate in evidence generation and value demonstration.
• Proven ability to influence and advocate across diverse internal and external stakeholder groups.
• Domestic and international travel will be required.

#J-18808-Ljbffr